Olanzapine Recruiting Phase 2 Trials for Vomiting / Chemotherapy-Induced Nausea and Vomiting (CINV) / Nausea Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03478605Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis